Oragenics, Inc.

Oragenics, Inc.verified

OGEN

Price:

$0.8516

Market Cap:

$3.55M

Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials rela...[Read more]

Industry

Biotechnology

IPO Date

2004-02-25

Stock Exchange

AMEX

Ticker

OGEN

The ROE as of December 2025 (TTM) for Oragenics, Inc. (OGEN) is -4705.41%

According to Oragenics, Inc.’s latest financial reports and current stock price. The company's current ROE is -4705.41%. This represents a change of 663.78% compared to the average of -0.71% of the last 4 quarters.

Oragenics, Inc. (OGEN) Historical ROE (quarterly & annually)

How has OGEN ROE performed in the past?

The mean historical ROE of Oragenics, Inc. over the last ten years is 328.11%. The current -4705.41% ROE has changed -1534.09% with respect to the historical average. Over the past ten years (40 quarters), OGEN's ROE was at its highest in in the December 2024 quarter at 1.58%. The ROE was at its lowest in in the March 2025 quarter at -1610.16%.

Quarterly (TTM)
Annual

Average

328.11%

Median

-108.20%

Minimum

-651.99%

Maximum

4.99%

Oragenics, Inc. (OGEN) ROE by Quarter and Year

Discovering the peaks and valleys of Oragenics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 493.64%

Maximum Annual ROE = 4.99%

Minimum Annual Increase = -864.98%

Minimum Annual ROE = -651.99%

Quarterly (TTM)
Annual
YearROEChange
20244.99%-864.98%
2023-651.99%493.64%
2022-109.83%85.15%
2021-59.32%-62.20%
2020-156.91%73.61%
2019-90.38%90.37%
2018-47.48%-55.45%
2017-106.57%-54.93%
2016-236.48%-4.47%
2015-247.54%341.93%

Oragenics, Inc. (OGEN) Average ROE

How has OGEN ROE performed in the past?

The current ROE of Oragenics, Inc. (OGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.41%

5-year avg

801.91%

10-year avg

328.11%

Oragenics, Inc. (OGEN) ROE vs. Peers

How is OGEN’s ROE compared to its peers?

Oragenics, Inc.’s ROE is less than AIM ImmunoTech Inc. (353.89%), greater than KALA BIO, Inc. (-2323.94%), greater than Ensysce Biosciences, Inc. (-386.70%), greater than Soligenix, Inc. (-274.80%), greater than Qualigen Therapeutics, Inc. (-72.97%), greater than Can-Fite BioPharma Ltd. (-182.93%), greater than Xenetic Biosciences, Inc. (-64.62%), greater than CNS Pharmaceuticals, Inc. (-130.12%), less than Kazia Therapeutics Limited (335.37%), greater than Titan Pharmaceuticals, Inc. (-108.55%),

Build a custom stock screener for Oragenics, Inc. (OGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oragenics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oragenics, Inc. (OGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oragenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Oragenics, Inc.'s ROE?

How is the ROE calculated for Oragenics, Inc. (OGEN)?

What is the highest ROE for Oragenics, Inc. (OGEN)?

What is the 3-year average ROE for Oragenics, Inc. (OGEN)?

What is the 5-year average ROE for Oragenics, Inc. (OGEN)?

How does the current ROE for Oragenics, Inc. (OGEN) compare to its historical average?